Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The M2 muscarinic acetylcholine receptor (M2 mAChR), encoded by the CHRM2 gene, is a G protein-coupled receptor primarily responsive to acetylcholine. It is highly expressed in cardiac tissue and plays a central role in mediating parasympathetic nervous system effects on heart function. It is also found in airway smooth muscle and the central nervous system. Activation leads to inhibition of adenylyl cyclase and activation of G-protein-gated potassium channels. It is a key target for drugs treating cardiac arrhythmias/bradycardia, asthma/COPD, and neurological disorders.
Agonist or antagonist binding modulates G protein activity, leading to changes in cAMP levels and ion channel conductance. Antagonists block acetylcholine binding and receptor activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on M2 Muscarinic Acetylcholine Receptor (M2 mAChR).